Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_assertion type Assertion NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_head.
- NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_assertion description "[The development of parathyroid carcinoma has been associated with inactivating mutations of the Hyperparathyroidism type 2 (HRPT2) gene encoding parafibromin, a member of the human RNA Polymerase II-Associated Factor Complex (hPAF) and functionally linked to the Wingless type (Wnt) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_provenance.
- NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_assertion evidence source_evidence_literature NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_provenance.
- NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_assertion SIO_000772 19148484 NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_provenance.
- NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_assertion wasDerivedFrom befree-20140225 NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_provenance.
- NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_assertion wasGeneratedBy ECO_0000203 NP572696.RAHHW8u2v71GW12H_wdDocOyU-g005GS1eWsuF6BbcNHI130_provenance.